Cargando…
Bioactive Compounds with Antiglioma Activity from Marine Species
The search for new chemical compounds with antitumor pharmacological activity is a necessary process for creating more effective drugs for each specific malignancy type. This review presents the outcomes of screening studies of natural compounds with high anti-glioma activity. Despite significant ad...
Autores principales: | , , , |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
MDPI
2021
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8389718/ https://www.ncbi.nlm.nih.gov/pubmed/34440090 http://dx.doi.org/10.3390/biomedicines9080886 |
_version_ | 1783742924049088512 |
---|---|
author | Khotimchenko, Rodion Bryukhovetskiy, Igor Khotimchenko, Maksim Khotimchenko, Yuri |
author_facet | Khotimchenko, Rodion Bryukhovetskiy, Igor Khotimchenko, Maksim Khotimchenko, Yuri |
author_sort | Khotimchenko, Rodion |
collection | PubMed |
description | The search for new chemical compounds with antitumor pharmacological activity is a necessary process for creating more effective drugs for each specific malignancy type. This review presents the outcomes of screening studies of natural compounds with high anti-glioma activity. Despite significant advances in cancer therapy, there are still some tumors currently considered completely incurable including brain gliomas. This review covers the main problems of the glioma chemotherapy including drug resistance, side effects of common anti-glioma drugs, and genetic diversity of brain tumors. The main emphasis is made on the characterization of natural compounds isolated from marine organisms because taxonomic diversity of organisms in seawaters significantly exceeds that of terrestrial species. Thus, we should expect greater chemical diversity of marine compounds and greater likelihood of finding effective molecules with antiglioma activity. The review covers at least 15 classes of organic compounds with their chemical formulas provided as well as semi-inhibitory concentrations, mechanisms of action, and pharmacokinetic profiles. In conclusion, the analysis of the taxonomic diversity of marine species containing bioactives with antiglioma activity is performed noting cytotoxicity indicators and to the tumor cells in comparison with similar indicators of antitumor agents approved for clinical use as antiglioblastoma chemotherapeutics. |
format | Online Article Text |
id | pubmed-8389718 |
institution | National Center for Biotechnology Information |
language | English |
publishDate | 2021 |
publisher | MDPI |
record_format | MEDLINE/PubMed |
spelling | pubmed-83897182021-08-27 Bioactive Compounds with Antiglioma Activity from Marine Species Khotimchenko, Rodion Bryukhovetskiy, Igor Khotimchenko, Maksim Khotimchenko, Yuri Biomedicines Review The search for new chemical compounds with antitumor pharmacological activity is a necessary process for creating more effective drugs for each specific malignancy type. This review presents the outcomes of screening studies of natural compounds with high anti-glioma activity. Despite significant advances in cancer therapy, there are still some tumors currently considered completely incurable including brain gliomas. This review covers the main problems of the glioma chemotherapy including drug resistance, side effects of common anti-glioma drugs, and genetic diversity of brain tumors. The main emphasis is made on the characterization of natural compounds isolated from marine organisms because taxonomic diversity of organisms in seawaters significantly exceeds that of terrestrial species. Thus, we should expect greater chemical diversity of marine compounds and greater likelihood of finding effective molecules with antiglioma activity. The review covers at least 15 classes of organic compounds with their chemical formulas provided as well as semi-inhibitory concentrations, mechanisms of action, and pharmacokinetic profiles. In conclusion, the analysis of the taxonomic diversity of marine species containing bioactives with antiglioma activity is performed noting cytotoxicity indicators and to the tumor cells in comparison with similar indicators of antitumor agents approved for clinical use as antiglioblastoma chemotherapeutics. MDPI 2021-07-25 /pmc/articles/PMC8389718/ /pubmed/34440090 http://dx.doi.org/10.3390/biomedicines9080886 Text en © 2021 by the authors. https://creativecommons.org/licenses/by/4.0/Licensee MDPI, Basel, Switzerland. This article is an open access article distributed under the terms and conditions of the Creative Commons Attribution (CC BY) license (https://creativecommons.org/licenses/by/4.0/). |
spellingShingle | Review Khotimchenko, Rodion Bryukhovetskiy, Igor Khotimchenko, Maksim Khotimchenko, Yuri Bioactive Compounds with Antiglioma Activity from Marine Species |
title | Bioactive Compounds with Antiglioma Activity from Marine Species |
title_full | Bioactive Compounds with Antiglioma Activity from Marine Species |
title_fullStr | Bioactive Compounds with Antiglioma Activity from Marine Species |
title_full_unstemmed | Bioactive Compounds with Antiglioma Activity from Marine Species |
title_short | Bioactive Compounds with Antiglioma Activity from Marine Species |
title_sort | bioactive compounds with antiglioma activity from marine species |
topic | Review |
url | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8389718/ https://www.ncbi.nlm.nih.gov/pubmed/34440090 http://dx.doi.org/10.3390/biomedicines9080886 |
work_keys_str_mv | AT khotimchenkorodion bioactivecompoundswithantigliomaactivityfrommarinespecies AT bryukhovetskiyigor bioactivecompoundswithantigliomaactivityfrommarinespecies AT khotimchenkomaksim bioactivecompoundswithantigliomaactivityfrommarinespecies AT khotimchenkoyuri bioactivecompoundswithantigliomaactivityfrommarinespecies |